Exclusive agreement to acquire Nudge Therapeutics includes their series of cGAS inhibitors. Nudge has developed novel potent small molecule cGAS inhibitors that prevents the overproduction of Type 1 interferons which are implicated in inflammatory and autoimmune diseases. The addition of…
